Terri Wilder, M.S.W.
Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.
Latest by Terri Wilder, M.S.W.
LGBTQ Health and Well-Being: Where Is the U.S. Right Now?
Tonia Poteat, Ph.D., PA-C, M.P.H., and Marlon M. Bailey, Ph.D., dive into the important takeaways of a major new report on sexual and gender diverse populations in the U.S.
How Can We Manage Pain Better in Older Adults Living With HIV?
“Telling them now that ‘the government is saying I need to decrease your opioids. ... Sorry you’re going to suffer,’ was just not satisfying to me as a physician,” says Maile Young Karris, M.D.
HIV Incidence Is Lower in States With More Generous Low-Income Food Benefits
“The message that needs to be communicated to people in power, and it needs to be communicated loud and frequently, is, ‘Look. Here’s the actual human cost of not enacting these kinds of policies. Here’s the potential benefit,’” says Aaron Richterman, M.D., M.P.H.
Will the Biden-Harris Administration Breathe Life Back Into Vital HIV and Hepatitis Programs?
We spoke with Amy Killelea at NASTAD, a major national health policy advocacy organization, about the priorities she sees in January 2021 and beyond.
Histoplasmosis and HIV in the U.S.: Often Forgotten, Never Gone
IDWeek 2020 provided a perfect opportunity to better understand the modern-day impact of histoplasmosis among Americans living with HIV—and to bone up on the basics.
For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key
The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.
HIV Clinicians Have Played a Key Role in U.S. COVID-19 Treatment Guidelines. We Spoke With One of Them.
COVID-19 Treatment Guidelines Panel member Arthur Kim, M.D., discusses the guidelines and the experience of treating COVID-19 from an HIV care provider’s perspective.
Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters
W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.
Smoking Rates Are Higher in the LGBTQ Community; Can More Inclusive Data Help?
Scout, Ph.D., the head of the National LGBT Cancer Network, lays out the current state of the interplay between nicotine, cancer, HIV, and people who are LGBTQ.
Are Monoclonal Antibodies the Future of COVID-19 Treatment?
Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.